Publications

Alves, J., et al., A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice. PLoS One, 2015. 10(12): p. e0144196.

Oliveira, L., et al., Group B streptococcus GAPDH is released upon cell lysis, associates with bacterial surface, and induces apoptosis in murine macrophages. PLoS One, 2012. 7(1): p. e29963.

Madureira, P., et al., Inhibition of IL-10 production by maternal antibodies against Group B Streptococcus GAPDH confers immunity to offspring by favoring neutrophil recruitment. PLoS Pathog, 2011. 7(11): p. e1002363.

Madureira, P., et al., Streptococcus agalactiae GAPDH is a virulence-associated immunomodulatory protein. J Immunol, 2007. 178(3): p. 1379-87.

Tiago Pereira Rodrigues. Study the accessibility of IL-10 locus in a murine model of Neonatal Sepsis. MSc Thesis in Bioengineering, 2017. FEUP, University of Porto.

Cristiana Andreia Pereira Nogueira. Evaluation of the efficacy of a peptide-based vaccine (PNV1) against multi-resistant gram-negative bacteria in a neonatal mice model. MSc Thesis in Bioengineering, 2017. FEUP, University of Porto.

Filipa Gláucia Rodrigues Lemos. Study of the cellular and molecular mechanism associated with neonatal susceptibility to bacterial infections. MSc Thesis in Biochemistry, 2016. FCUP, University of Porto.

Pedro Madureira & Paula Ferreira (2015). Vaccine for Immunocompromised Hosts. WO2015/189422.

Pedro Madureira (2020). Immunogenic compositions. European Patent Application No. 20398008.1